The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Hospital admissions/visits associated with drug–drug interactions: a systematic review and meta‐analysis
Abstract
Purpose: To estimate prevalences of hospital admissions/visits associated with actual drug–drug interactions (DDIs) and examine the effect of study design (prospective vs. retrospective), population (all ages or adults), and method of detecting DDIs on reported prevalences. Methods: PubMed, International Pharmaceutical Abstracts, Excerpta Medica Database, Cumulative Index to Nursing and Allied Health Literature plus, and the Cochrane Database of Systematic Reviews up to October 2013 were searched for observational studies examining actual DDIs, in any language. The outcomes in this study were DDI prevalence rates in total populations, DDI prevalence rates in total adverse drug reaction patients, and frequency (%) of each pair of DDIs. Results: Thirteen studies met our inclusion criteria. The median DDI prevalence rate for hospital admissions was 1.1% (367 DDI cases/47 976 patients, interquartile range [IQR] 0.4–2.4%). The median DDI prevalence rate for hospital visits was 0.1% (20 DDI cases/23 607 patients, IQR 0.0–0.3%). In adverse drug reaction patients, the median DDI prevalence rate for hospital admissions (308 DDI cases/1683 patients) and hospital visits (8 DDI cases/90 patients) were 22.2% (IQR 16.6–36.0%) and 8.9%, respectively. Medical record, interview, drug interaction screening program, adverse reaction report, and electronic medical record were identified as methods used for detecting DDIs. Non‐steroidal anti‐inflammatory drugs were most commonly involved in hospital admission associated DDIs, whereas warfarin was frequently involved in DDIs detected at hospital visits as outpatients/emergencies. Conclusions: Drug–drug interactions are a significant cause of hospital admissions and hospital visits. Improved DDI information gathering could help to reduce such adverse effects from DDIs, especially for patients using non‐steroidal anti‐inflammatory drugs and warfarin. Copyright © 2014 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Assessing Risk of Bias in Included Studies
Higgins, J. P., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch8 · Cited by 3,396
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Malfertheiner, P., Chan, F. K., & McColl, K. E. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60938-7 · Cited by 1,488
Drug-Drug Interactions Among Elderly Patients Hospitalized for Drug Toxicity
Juurlink, D. N., Mamdani, M., Kopp, A., Laupacis, A., & Redelmeier, D. A. (2003) · JAMA · doi:10.1001/jama.289.13.1652 · Cited by 761
Hospital Admissions Resulting from Preventable Adverse Drug Reactions
McDonnell, P. J., & Jacobs, M. R. (2002) · The Annals of Pharmacotherapy · doi:10.1345/1542-6270(2002)036<1331:harfpa>2.0.co;2 · Cited by 587
The challenge of managing drug interactions in elderly people
Mallet, L., Spinewine, A., & Huang, A. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61092-7 · Cited by 537
Primary and Secondary Prevention of Cardiovascular Disease
Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., & Spencer, F. A. (2012) · Chest · doi:10.1378/chest.11-2306 · Cited by 476
Pharmacotherapy: A Pathophysiologic Approach
Somberg, J. C. (2007) · American Journal of Therapeutics · doi:10.1097/mjt.0b013e318145a6ba · Cited by 360
Avoiding Central Nervous System Bleeding During Antithrombotic Therapy: Recent Data and Ideas
Hart, R. G., Tonarelli, S. B., & Pearce, L. A. (2005) · Stroke · doi:10.1161/01.str.0000170642.39876.f2 · Cited by 355
Hospitalisations and emergency department visits due to drug–drug interactions: a literature review
Becker, M. L., Kallewaard, M., Caspers, P. W., Visser, L. E., Leufkens, H. G., & Stricker, B. H. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1351 · Cited by 333
Köhler, G. I., Bode-Böger, S. M., Busse, R., Hoopmann, M., Welte, T., & Böger, R. H. (2000) · Int. Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp38504 · Cited by 271
Drug-Drug Interactions Associated with Length of Stay and Cost of Hospitalization
Moura, C. S., Acurcio, F. A., & Belo, N. O. (2009) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j35c7z · Cited by 247
The influence of verapamil on serum digoxin concentration.
Klein, H. O., Lang, R., Weiss, E., Di Segni, E., Libhaber, C., Guerrero, J., & Kaplinsky, E. (1982) · Circulation · doi:10.1161/01.cir.65.5.998 · Cited by 208
Suspected adverse drug events requiring emergency department visits or hospital admissions
Raschetti, R., Morgutti, M., Menniti-Ippolito, F., Belisari, A., Rossignoli, A., Longhini, P., & La Guidara, C. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050582 · Cited by 183
In-hospital care pathways for stroke
Kwan, J. S. K., & Sandercock, P. A. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002924.pub2 · Cited by 144
Performance of Community Pharmacy Drug Interaction Software
Hazlet, T. K., Lee, T. A., Hansten, P. D., & Horn, J. R. (2001) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)31230-x · Cited by 141
Drug-related emergency department visits and hospital admissions
Prince, B. S., Goetz, C. M., Rihn, T. L., & Olsky, M. (1992) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/49.7.1696 · Cited by 131
Vonbach, P., Dubied, A., Krähenbühl, S., & Beer, J. H. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.12.002 · Cited by 119
The Accuracy and Completeness of Data Collected by Prospective and Retrospective Methods
Nagurney, J. T., Brown, D., Sane, S., Weiner, J. B., Wang, A. C., & Chang, Y. (2005) · Academic Emergency Medicine · doi:10.1197/j.aem.2005.04.021 · Cited by 118
Ko, Y., Malone, D. C., Skrepnek, G. H., Armstrong, E. P., Murphy, J. E., Abarca, J., Rehfeld, R. A., Reel, S., & Woosley, R. L. (2008) · Drug Safety · doi:10.2165/00002018-200831060-00007 · Cited by 115
Adverse Drug Events Associated with Hospital Admission
Peyrière, H., Cassan, S., Floutard, E., Rivière, S., Blayac, J., Hillaire‐Buys, D., Quellec, A. L., & Hansel, S. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c126 · Cited by 102
Pharmacokinetic interactions between digoxin and other drugs
Marcus, G. M. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80466-6 · Cited by 93
Abarca, J., Colon, L. R., Wang, V. S., et al. (2006) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2006.12.5.383 · Cited by 89
Incidence and Contributors to Potential Drug‐Drug Interactions in Hospitalized Patients
Reimche, L., Forster, A. J., & van Walraven, C. (2010) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010378858 · Cited by 79
Drug-related admissions to an Australian hospital
Stanton, L. A., Peterson, G. M., Rumble, R. H., et al. (1994) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1994.tb00691.x · Cited by 77
Clinically important potential drug-drug interactions in outpatient settings
Aparasu, R. R., Baer, R. K., & Aparasu, A. (2007) · Research in Social and Administrative Pharmacy · doi:10.1016/j.sapharm.2006.12.002 · Cited by 77
Principles of Patient Safety in Pediatrics
National Initiative for Children's Health Care Quality Project Advisory Committee (2001) · PEDIATRICS · doi:10.1542/peds.107.6.1473 · Cited by 67
Egger, S. S., Bravo, A. E. R., Hess, L., Schlienger, R. G., & hl, S. K. H. (2007) · Drugs & Aging · doi:10.2165/00002512-200724050-00006 · Cited by 65
Drug-Related Emergency Department Visits in an Elderly Veteran Population
Yee, J. L., Hasson, N. K., & Schreiber, D. H. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e541 · Cited by 63
Skvrce, N. M., Šarinić, V. M., Mucalo, I., Krnić, D., Božina, N., & Tomić, S. (2011) · Croatian Medical Journal · doi:10.3325/cmj.2011.52.604 · Cited by 61
von Euler, M., Eliasson, E., Öhlén, G., & Bergman, U. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1154 · Cited by 60
Incidence and risk of potential adverse drug interactions in the emergency room
Heininger-Rothbucher, D., Bischinger, S., Ulmer, H., Pechlaner, C., Speer, G., & Wiedermann, C. J. (2001) · Resuscitation · doi:10.1016/s0300-9572(00)00363-4 · Cited by 56
Admissions to a medical intensive care unit related to adverse drug reactions
Rivkin, A. M. (2007) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060641 · Cited by 55
Zins, B. J., Sandborn, W. J., Mays, D. C., Lawson, G. M., McKinney, J. A., Tremaine, W. J., Mahoney, D. W., Zinsmeister, A. R., Hurt, R. D., Offord, K. P., et al. (1997) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1997.tb04320.x · Cited by 39
Potential of Drug Interactions among Hospitalized Cancer Patients in a Developing Country.
Ardakani, M. T., Kazemian, K., Salamzadeh, J., & Mehdizadeh, M. (2013) · PubMed Central · Cited by 16
Cited by
Edrees, H., Amato, M. G., Wong, A., Seger, D. L., & Bates, D. W. (2020) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaa034 · Cited by 64
Horn, J., & Ueng, S. (2019) · Annals of Pharmacotherapy · doi:10.1177/1060028019863419 · Cited by 26
Metadata
- Authors
- Dechanont, S., Maphanta, S., Butthum, B., & Kongkaew, C.
- Venue
- Pharmacoepidemiology and Drug Safety
- Publisher
- Wiley
- Published
- 2014-03-10
- Volume
- 23
- Issue
- 5
- Pages
- 489-497
- ISSN
- 1053-8569 (ISSN-L)
- 1099-1557
- OpenAlex
- W1762915406
- Cited by
- 283
- References
- 36
- FWCI
- 1.00
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.